Summit Therapeutics PLC (SMMT.OQ)
Get access to over 18 million research reports from over 1,700 sources.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
- private equity
- third-party document and information retrieval
- and much, much more…
|60||2013||Non-Executive Chairman of the Board|
|59||2012||Chief Executive Officer, Executive Director|
|42||2014||Chief Financial Officer|
|2017||Chief Operating Officer, President - Research and Development|
|63||2015||Chief Medical Officer|
- BRIEF-Summit Therapeutics enters exclusive licence agreement with Eurofarma Laboratórios
- UK Stocks-Factors to watch on Dec 6
- BRIEF-Summit highlights DMD biomarker phase 2 clinical trial data in presentations at 22nd WMS Congress
- BRIEF-Summit Therapeutics announces pricing of public offering $12.00 per ADS
- BRIEF-Summit Therapeutics announces proposed public offering of $15 mln of American Depositary shares